Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.
Athyrium advises funds with over $3.7 billion of committed capital.
Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.
Athyrium advises funds with over $3.7 billion of committed capital.
Deerfield Healthcare Technology Acquisitions Corp. Announces Closing of Business Combination With CareMax
Anthem, Inc. Completes Acquisition of MMM Holdings, LLC and Affiliates From InnovaCare Health, L.P.
FDA Grants Priority Review for New Drug Application for Oleogel-S10
Progenity Launches Strategic Transformation into Biotech Company, Focusing on Robust R&D Pipeline
BioCryst Receives UK Approval of ORLADEYO™ to Prevent Heart Attacks
Water's Edge Dermatology and Riverchase Dermatology Partner with Goodman Dermatology
Progenity Announces $40 Million Private Placement
We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Privacy Policy. By closing this message box or continuing to use our website you consent to our use of cookies.
